Topics In Demand
Notification
New

No notification found.

Use of Artificial Intelligence and Machine Learning for Safety Signal Management
Use of Artificial Intelligence and Machine Learning for Safety Signal Management

April 8, 2022

168

0

Detecting and understanding safety issues associated with drug can be achieved through early surveillance and appropriate risk minimization measures. It is a lifelong activity for the drug, designed to ensure early detection of safety signals, identify and mitigate the risks, and minimize the likelihood of possible safety issues. 

PV signal detection has been traditionally performed using manual and semi-automated means based on statistical analyses and/or expert judgement.  Although useful for generating signals, these methods often fail to identify signals that require further investigation as they are limited to quantitative data and conventional statistical tools, which cannot capture all types of patterns in vast amounts of complex heterogeneous data such as that generated from E2B(R3) ICSRs, literature, social media, data from clinical trials and electronic health records (EHRs). 

Artificial Intelligence (AI) and Machine Learning is increasingly used across the pharmaceutical industry for a wide range of applications where computers can provide more accurate results than humans, e.g., drug discovery, medical imaging, and pharmacovigilance (PV) signal detection.  For safety signal management (SSM), AI techniques can be applied to improve the early detection from multiple sources for a potentially serious threat, as well as improve PV performance metrics (e.g., timeliness and completeness). 

Improving identification and classification: 

AI-based approaches are well–suited to address the challenges of proper identification and classification of the severity levels of safety alerts. Because the large amount of historical and real-world data on safety issues and the need for standardised decision tree processes can be delivered effectively via Machine Learning algorithms. By using advanced analytic techniques, huge data can be grouped better, and associations can be identified near to perfection.

 

Predictive signal detection:

AI can assist the signal evaluators to make more informed observations with data-driven algorithms. For example, by using statistical methods like BCPNN, Multivariable logistic regression analysis predicting for selection and prioritization of potential signals.  This suggests that AI can increase timeliness and completeness by identifying patterns in the data that would not have been detected by traditional methods. 

Safety experts are likely to get lesser trial data (due to expedited regulatory approvals) and more real-world data (due to increased reporting requirements) than in the past, so predictive signal detection (using AI/ML technology) is a valuable tool. 

Better evaluation of risk-to-benefit ratio: 

For better risk-benefit profiles and to reduce the time required to create such profiles, risk evaluators are increasing the number and types of datasets with which they conduct signal detection. As a result, they need the help of ML algorithms to understand the differences between the signal scores across multiple datasets, including the method for summing them. The aggregated case data provide a more holistic picture of signals than any single case, and this aggregated data allows for signal discovery-looking for patterns that may indicate previously unknown risks. 

Better analytics: 

The use of Artificial Intelligence (AI) and Machine Learning is increasingly used for better analytics in safety signal management. Different types of data streams have been used in recent research to gain a more complete picture of specific safety issues that appear in the same or similar databases. Analytics capabilities are expanding to take advantage of these new data streams as the number of inputs increases. Faster and better analytics makes it easier for the reviewers to detect cases of interest by prioritizing those flagged as higher risk. 


That the contents of third-party articles/blogs published here on the website, and the interpretation of all information in the article/blogs such as data, maps, numbers, opinions etc. displayed in the article/blogs and views or the opinions expressed within the content are solely of the author's; and do not reflect the opinions and beliefs of NASSCOM or its affiliates in any manner. NASSCOM does not take any liability w.r.t. content in any manner and will not be liable in any manner whatsoever for any kind of liability arising out of any act, error or omission. The contents of third-party article/blogs published, are provided solely as convenience; and the presence of these articles/blogs should not, under any circumstances, be considered as an endorsement of the contents by NASSCOM in any manner; and if you chose to access these articles/blogs , you do so at your own risk.


Datafoundry is a company with a vision to bring the power of AI/ML to Life Sciences and Health Care industry for better health outcomes.

© Copyright nasscom. All Rights Reserved.